Hemodialysis-induced cardiovascular disease

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Cardiovascular disease (CVD) is the leading cause of mortality in end-stage renal disease (ESRD) patients, accounting for over 50% of deaths.
• Renal dysfunction leads to various cardiovascular complications, including fluid overload, uremic cardiomyopathy, secondary hyperparathyroidism, anemia, dyslipidemia, and accumulation of uremic toxins.
• Conventional hemodialysis (HD) can impose additional myocardial stress and injury in ESRD patients.

Purpose of the Study:

• To provide a comprehensive overview of cardiovascular changes in chronic kidney disease (CKD) and ESRD.
• To describe the mechanisms underlying hemodialysis-induced myocardial injury.
• To compare hemodialysis with alternative treatment modalities regarding cardiovascular disease (CVD) outcomes and discuss potential management strategies.

Main Methods:

• Literature review of cardiovascular changes in CKD and ESRD.
• Analysis of reported mechanisms for HD-induced myocardial injury.
• Comparative assessment of HD and other treatment modalities for CVD in ESRD.

Main Results:

• ESRD patients face a high risk of CVD due to uremic complications and HD treatment.
• Specific factors contributing to CVD in ESRD include fluid overload, uremic cardiomyopathy, and toxin accumulation.
• HD can exacerbate cardiovascular compromise through direct myocardial stress and injury.

Conclusions:

• Understanding the multifaceted cardiovascular risks in ESRD is crucial for patient management.
• Further research into the mechanisms of HD-induced myocardial injury may lead to improved treatment strategies.
• A comparative analysis of treatment modalities can inform clinical decisions to mitigate CVD risk in ESRD patients.